MRMD
MariMed Inc.
Price Chart
Latest Quote
$0.07
+0.00 (+2.88%)
Current Price
| Previous Close | $0.07 |
| Open | $0.07 |
| Day High | $0.07 |
| Day Low | $0.07 |
| Volume | 25,000 |
Stock Information
| Shares Outstanding | 399.27M |
| Total Debt | $91.21M |
| Cash Equivalents | $7.94M |
| Revenue | $161.40M |
| Net Income | $-12.76M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $27.11M |
| EPS (TTM) | $-0.04 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $114.27M |
| Sales | $161.40M |
| Income | $-12.76M |
| Book/sh | $0.12 |
| Cash/sh | $0.02 |
| Employees | 808 |
Financial Ratios
| Quick Ratio | 0.27 |
| Current Ratio | 0.95 |
| Debt/Eq | 170.66 |
Returns & Margins
| ROA | -0.38% |
| ROE | -20.01% |
| Gross Margin | 35.98% |
| Operating Margin | 0.74% |
| Profit Margin | -7.91% |
Ownership
| Insider Ownership | 14.55% |
| Institutional Ownership | 0.24% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.26 |
| P/S | 0.17 |
| P/B | 0.56 |
Analyst Data
| Recommendation | none |
| Target Price | $0.25 |
Technical Indicators
| SMA20 | $0.07 |
| SMA50 | $0.08 |
| SMA200 | $0.10 |
| RSI | 35.48 |
| ATR | 0.0052 |
| Shares Float | 332.51M |
| Volatility | 1.32 |
| Rel Volume | 0.04 |
Performance History
| Week | -1.59% |
| Month | -9.47% |
| Quarter | -14.05% |
| 6 Months | -38.83% |
| YTD | -24.56% |
| Year | -4.37% |
| 3 Years | -82.59% |
| 5 Years | -93.07% |
| 10 Years | -51.50% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.07 | 25,000 |
| 2026-06-23 | $0.06 | 520,500 |
| 2026-06-22 | $0.07 | 467,200 |
| 2026-06-18 | $0.07 | 223,400 |
| 2026-06-17 | $0.07 | 291,200 |
| 2026-06-16 | $0.07 | 348,500 |
| 2026-06-15 | $0.07 | 784,500 |
| 2026-06-12 | $0.07 | 921,500 |
| 2026-06-11 | $0.07 | 1,090,200 |
| 2026-06-10 | $0.07 | 219,700 |
| 2026-06-09 | $0.07 | 624,600 |
| 2026-06-08 | $0.08 | 932,200 |
| 2026-06-05 | $0.08 | 1,202,800 |
| 2026-06-04 | $0.08 | 486,100 |
| 2026-06-03 | $0.08 | 239,500 |
| 2026-06-02 | $0.08 | 447,400 |
| 2026-06-01 | $0.08 | 788,300 |
| 2026-05-29 | $0.08 | 452,900 |
| 2026-05-28 | $0.08 | 1,036,400 |
| 2026-05-27 | $0.08 | 546,000 |
| 2026-05-26 | $0.08 | 581,100 |
About MariMed Inc.
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is headquartered in Norwood, Massachusetts.
đ° Latest News
Here's Why MariMed Inc. (MRMD) Could be Great Choice for a Bottom Fisher
Zacks âĸ 2026-06-15T13:55:02Z
MariMed Inc (MRMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
GuruFocus.com âĸ 2026-05-14T23:03:20ZMariMed Inc. (MRMD) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-13T22:25:01Z
Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-12T23:00:04Z
Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-11T13:20:06Z
Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T23:05:28Z
MariMed Inc (MRMD) Q4 2025 Earnings Call Highlights: Steady Revenue Growth Amid Market Challenges
GuruFocus.com âĸ 2026-03-12T19:01:18ZMariMed Inc (MRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry Challenges
GuruFocus.com âĸ 2025-11-06T19:08:08Z
MariMed Inc. (MRMD) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2025-11-06T00:35:02Z
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
Zacks âĸ 2025-10-13T11:58:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $95,096,000 | $82,679,000 | $70,053,000 | $55,201,000 |
| Cost Of Revenue | $95,096,000 | $82,679,000 | $70,053,000 | $55,201,000 |
| Total Revenue | $157,964,000 | $148,598,000 | $134,010,000 | $121,464,000 |
| Operating Revenue | $154,425,000 | $144,305,000 | $134,010,000 | $121,464,000 |
| Expenses | ||||
| Interest Expense | $6,944,000 | $9,185,000 | $1,693,000 | $2,356,000 |
| Total Expenses | $154,437,000 | $133,400,000 | $108,928,000 | $92,739,000 |
| Other Income Expense | $-665,000 | $-12,879,000 | $-4,840,000 | $-2,662,000 |
| Other Non Operating Income Expenses | $-50,000 | $-1,635,000 | $-127,000 | $-800,000 |
| Net Non Operating Interest Income Expense | $-6,830,000 | $-8,915,000 | $-734,000 | $-2,247,000 |
| Interest Expense Non Operating | $6,944,000 | $9,185,000 | $1,693,000 | $2,356,000 |
| Operating Expense | $59,341,000 | $50,721,000 | $38,875,000 | $37,538,000 |
| Selling And Marketing Expense | $6,664,000 | $5,977,000 | $3,736,000 | $1,625,000 |
| General And Administrative Expense | $52,677,000 | $44,744,000 | $35,139,000 | $35,913,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,164,000 | $-16,031,000 | $13,468,000 | $7,225,000 |
| Net Interest Income | $-6,830,000 | $-8,915,000 | $-734,000 | $-2,247,000 |
| Interest Income | $114,000 | $270,000 | $959,000 | $109,000 |
| Normalized Income | $-11,678,150 | $-7,148,240 | $16,833,082 | $8,584,260 |
| Net Income From Continuing And Discontinued Operation | $-12,164,000 | $-16,031,000 | $13,468,000 | $7,225,000 |
| Total Operating Income As Reported | $2,912,000 | $14,385,000 | $20,369,000 | $26,863,000 |
| Net Income Common Stockholders | $-12,164,000 | $-16,031,000 | $13,468,000 | $7,225,000 |
| Net Income | $-12,164,000 | $-16,031,000 | $13,468,000 | $7,225,000 |
| Net Income Including Noncontrolling Interests | $-12,127,000 | $-16,007,000 | $13,614,000 | $7,624,000 |
| Net Income Continuous Operations | $-12,127,000 | $-16,007,000 | $13,614,000 | $7,624,000 |
| Pretax Income | $-3,968,000 | $-6,596,000 | $19,508,000 | $23,816,000 |
| Special Income Charges | $-615,000 | $-11,244,000 | $-4,713,000 | $-1,862,000 |
| Interest Income Non Operating | $114,000 | $270,000 | $959,000 | $109,000 |
| Operating Income | $3,527,000 | $15,198,000 | $25,082,000 | $28,725,000 |
| Gross Profit | $62,868,000 | $65,919,000 | $63,957,000 | $66,263,000 |
| Earnings From Equity Interest | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.04 | $0.04 | $0.02 |
| Basic EPS | $-0.03 | $-0.04 | $0.04 | $0.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $-129,150 | $-2,361,240 | $-1,347,918 | $-502,740 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $14,449,000 | $22,407,000 | $30,628,000 | $30,822,000 |
| Total Unusual Items | $-615,000 | $-11,244,000 | $-4,713,000 | $-1,862,000 |
| Total Unusual Items Excluding Goodwill | $-615,000 | $-11,244,000 | $-4,713,000 | $-1,862,000 |
| Reconciled Depreciation | $10,858,000 | $8,574,000 | $4,714,000 | $2,788,000 |
| EBITDA (Bullshit earnings) | $13,834,000 | $11,163,000 | $25,915,000 | $28,960,000 |
| EBIT | $2,976,000 | $2,589,000 | $21,201,000 | $26,172,000 |
| Diluted Average Shares | $379,153,000 | $363,403,000 | $380,289,000 | $372,397,000 |
| Basic Average Shares | $379,153,000 | $363,403,000 | $337,697,000 | $326,467,000 |
| Diluted NI Availto Com Stockholders | $-12,164,000 | $-16,031,000 | $13,468,000 | $7,225,000 |
| Minority Interests | $-37,000 | $-24,000 | $-146,000 | $-399,000 |
| Tax Provision | $8,159,000 | $9,411,000 | $5,894,000 | $16,192,000 |
| Other Special Charges | $50,000 | $10,431,000 | $127,000 | $800,000 |
| Write Off | $-336,000 | $118,000 | $3,752,000 | $1,862,000 |
| Restructuring And Mergern Acquisition | $951,000 | $695,000 | $961,000 | $0 |
| Selling General And Administration | $59,341,000 | $50,721,000 | $38,875,000 | $37,538,000 |
| Other Gand A | $25,618,000 | $22,132,000 | $20,735,000 | $27,561,000 |
| Salaries And Wages | $27,059,000 | $22,612,000 | $14,404,000 | $8,352,000 |
| Gain On Sale Of Security | - | - | - | $-1,106,593 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $27,177,000 | $42,559,000 | $36,541,000 | $35,632,000 |
| Total Assets | $206,989,000 | $196,123,000 | $152,202,000 | $123,205,000 |
| Total Non Current Assets | $153,480,000 | $144,691,000 | $108,056,000 | $78,592,000 |
| Other Non Current Assets | $11,219,000 | $12,537,000 | $1,024,000 | $98,000 |
| Non Current Note Receivables | $840,000 | $814,000 | $7,467,000 | $8,987,000 |
| Goodwill And Other Intangible Assets | $34,451,000 | $29,005,000 | $22,280,000 | $2,230,000 |
| Other Intangible Assets | $18,639,000 | $17,012,000 | $14,201,000 | $162,000 |
| Current Assets | $53,509,000 | $51,432,000 | $44,146,000 | $44,613,000 |
| Other Current Assets | $3,389,000 | $3,512,000 | $7,282,000 | $1,440,000 |
| Inventory | $33,488,000 | $25,306,000 | $19,477,000 | $9,768,000 |
| Receivables | $9,350,000 | $7,881,000 | $7,527,000 | $3,471,000 |
| Other Receivables | $556,000 | $630,000 | $704,000 | $1,678,000 |
| Notes Receivable | $52,000 | $52,000 | $2,637,000 | $127,000 |
| Accounts Receivable | $8,742,000 | $7,199,000 | $4,157,000 | $1,666,000 |
| Allowance For Doubtful Accounts Receivable | $-255,000 | $-764,000 | $-4,603,000 | $-41,401,000 |
| Gross Accounts Receivable | $8,997,000 | $7,963,000 | $8,760,000 | $43,067,000 |
| Cash Cash Equivalents And Short Term Investments | $7,282,000 | $14,733,000 | $9,860,000 | $29,934,000 |
| Cash And Cash Equivalents | $7,282,000 | $14,645,000 | $9,737,000 | $29,683,000 |
| Debt | ||||
| Net Debt | $67,704,000 | $51,730,000 | $19,980,000 | - |
| Total Debt | $88,467,000 | $80,125,000 | $35,861,000 | $24,366,000 |
| Long Term Debt And Capital Lease Obligation | $79,335,000 | $76,247,000 | $30,577,000 | $21,858,000 |
| Long Term Debt | $69,860,000 | $65,652,000 | $25,943,000 | $17,262,000 |
| Current Debt And Capital Lease Obligation | $9,132,000 | $3,878,000 | $5,284,000 | $2,508,000 |
| Current Debt | $5,126,000 | $723,000 | $3,774,000 | $1,410,000 |
| Other Current Borrowings | $5,126,000 | $723,000 | $3,774,000 | $1,410,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $147,113,000 | $126,209,000 | $94,892,000 | $86,906,000 |
| Total Non Current Liabilities Net Minority Interest | $98,435,000 | $95,347,000 | $68,402,000 | $59,683,000 |
| Other Non Current Liabilities | $100,000 | $100,000 | $100,000 | $100,000 |
| Current Liabilities | $48,678,000 | $30,862,000 | $26,490,000 | $27,223,000 |
| Payables And Accrued Expenses | $39,546,000 | $26,984,000 | $21,206,000 | $24,715,000 |
| Payables | $35,111,000 | $23,435,000 | $18,115,000 | $21,566,000 |
| Total Tax Payable | $21,922,000 | $14,434,000 | $11,489,000 | $16,467,000 |
| Income Tax Payable | $21,922,000 | $14,434,000 | $11,489,000 | $16,467,000 |
| Accounts Payable | $13,189,000 | $9,001,000 | $6,626,000 | $5,099,000 |
| Other Current Liabilities | - | - | - | $1,920 |
| Current Notes Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $61,628,000 | $71,564,000 | $58,821,000 | $37,862,000 |
| Total Equity Gross Minority Interest | $59,876,000 | $69,914,000 | $57,310,000 | $36,299,000 |
| Stockholders Equity | $61,628,000 | $71,564,000 | $58,821,000 | $37,862,000 |
| Retained Earnings | $-112,119,000 | $-99,955,000 | $-83,924,000 | $-97,392,000 |
| Preferred Securities Outside Stock Equity | $19,000,000 | $19,000,000 | $37,725,000 | $37,725,000 |
| Long Term Equity Investment | $0 | $221,000 | $0 | $0 |
| Other Equity Interest | - | - | $39,000 | - |
| Other | ||||
| Ordinary Shares Number | $381,476,581 | $375,126,352 | $341,474,728 | $334,030,348 |
| Share Issued | $381,476,581 | $375,126,352 | $341,474,728 | $334,030,348 |
| Tangible Book Value | $27,177,000 | $42,559,000 | $36,541,000 | $35,632,000 |
| Invested Capital | $136,614,000 | $137,939,000 | $88,538,000 | $56,534,000 |
| Working Capital | $4,831,000 | $20,570,000 | $17,656,000 | $17,390,000 |
| Capital Lease Obligations | $13,481,000 | $13,750,000 | $6,144,000 | $5,694,000 |
| Total Capitalization | $131,488,000 | $137,216,000 | $84,764,000 | $55,124,000 |
| Minority Interest | $-1,752,000 | $-1,650,000 | $-1,511,000 | $-1,563,000 |
| Additional Paid In Capital | $173,366,000 | $171,144,000 | $142,365,000 | $134,920,000 |
| Capital Stock | $381,000 | $375,000 | $341,000 | $334,000 |
| Common Stock | $381,000 | $375,000 | $341,000 | $334,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $9,475,000 | $10,595,000 | $4,634,000 | $4,596,000 |
| Current Capital Lease Obligation | $4,006,000 | $3,155,000 | $1,510,000 | $1,098,000 |
| Current Accrued Expenses | $4,435,000 | $3,549,000 | $3,091,000 | $3,149,000 |
| Investments And Advances | $0 | $221,000 | $0 | $0 |
| Investmentsin Associatesat Cost | $0 | $221,000 | $0 | $0 |
| Goodwill | $15,812,000 | $11,993,000 | $8,079,000 | $2,068,000 |
| Net PPE | $106,970,000 | $102,114,000 | $77,285,000 | $67,277,000 |
| Accumulated Depreciation | $-21,645,000 | $-14,916,000 | $-10,224,000 | $-6,954,000 |
| Gross PPE | $128,615,000 | $117,030,000 | $87,509,000 | $74,231,000 |
| Construction In Progress | $80,000 | $427,000 | $4,761,000 | $10,569,000 |
| Other Properties | $44,697,000 | $38,462,000 | $22,660,000 | $14,872,000 |
| Machinery Furniture Equipment | $21,854,000 | $18,585,000 | $12,096,000 | $9,109,000 |
| Buildings And Improvements | $55,833,000 | $54,737,000 | $43,542,000 | $35,231,000 |
| Land And Improvements | $6,151,000 | $4,819,000 | $4,450,000 | $4,450,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $10,344,000 | $7,415,000 | $5,934,000 | $3,830,000 |
| Work In Process | $4,759,000 | $9,663,000 | $7,635,000 | $4,661,000 |
| Raw Materials | $18,385,000 | $8,228,000 | $5,908,000 | $1,277,000 |
| Other Short Term Investments | $0 | $88,000 | $123,000 | $251,000 |
| Duefrom Related Parties Current | - | $105,000 | $29,000 | $0 |
| Dueto Related Parties Current | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,887,000 | $-12,846,000 | $-5,430,000 | $17,289,000 |
| Operating Activities | ||||
| Operating Cash Flow | $6,785,000 | $7,910,000 | $7,311,000 | $35,855,000 |
| Cash Flow From Continuing Operating Activities | $6,785,000 | $7,910,000 | $7,311,000 | $35,855,000 |
| Operating Gains Losses | $231,000 | $11,337,000 | $-954,000 | $1,183,000 |
| Investing Activities | ||||
| Capital Expenditure | $-12,672,000 | $-20,756,000 | $-12,741,000 | $-18,566,000 |
| Investing Cash Flow | $-17,133,000 | $-25,985,000 | $-26,244,000 | $-16,624,000 |
| Cash Flow From Continuing Investing Activities | $-17,133,000 | $-25,985,000 | $-26,244,000 | $-16,624,000 |
| Net Other Investing Changes | $-155,000 | $-856,000 | $144,000 | $477,000 |
| Financing Activities | ||||
| Financing Cash Flow | $2,985,000 | $22,983,000 | $-1,013,000 | $7,453,000 |
| Cash Flow From Continuing Financing Activities | $2,985,000 | $22,983,000 | $-1,013,000 | $7,453,000 |
| Cash Dividends Paid | $-139,000 | $-158,000 | $-259,000 | $-410,000 |
| Net Other Financing Charges | - | $-3,339,000 | $-2,000,000 | $-387,000 |
| Issuance Of Capital Stock | - | - | $0 | $23,000,000 |
| Common Stock Dividend Paid | - | - | $-259,000 | $-410,000 |
| Net Preferred Stock Issuance | - | - | $0 | $23,000,000 |
| Preferred Stock Issuance | - | - | $0 | $23,000,000 |
| Other | ||||
| Repayment Of Debt | $-3,116,000 | $-56,347,000 | $-1,764,000 | $-17,617,000 |
| Issuance Of Debt | $6,240,000 | $82,718,000 | $3,000,000 | $2,735,000 |
| Interest Paid Supplemental Data | $6,689,000 | $5,654,000 | $1,744,000 | $1,975,000 |
| Income Tax Paid Supplemental Data | $877,000 | $6,419,000 | $14,567,000 | $621,000 |
| End Cash Position | $7,282,000 | $14,645,000 | $9,737,000 | $29,683,000 |
| Beginning Cash Position | $14,645,000 | $9,737,000 | $29,683,000 | $2,999,000 |
| Changes In Cash | $-7,363,000 | $4,908,000 | $-19,946,000 | $26,684,000 |
| Proceeds From Stock Option Exercised | $0 | $109,000 | $10,000 | $132,000 |
| Net Issuance Payments Of Debt | $3,124,000 | $26,371,000 | $1,236,000 | $-14,882,000 |
| Net Long Term Debt Issuance | $3,124,000 | $26,371,000 | $1,236,000 | $-14,882,000 |
| Long Term Debt Payments | $-3,116,000 | $-56,347,000 | $-1,764,000 | $-17,617,000 |
| Long Term Debt Issuance | $6,240,000 | $82,718,000 | $3,000,000 | $2,735,000 |
| Net Investment Purchase And Sale | $44,000 | $-261,000 | $0 | $1,475,000 |
| Sale Of Investment | $44,000 | $0 | $0 | $1,475,000 |
| Purchase Of Investment | $0 | $-261,000 | $0 | - |
| Net Business Purchase And Sale | $-4,350,000 | $-4,112,000 | $-13,647,000 | $-10,000 |
| Purchase Of Business | $-4,350,000 | $-4,112,000 | $-13,647,000 | $-10,000 |
| Net Intangibles Purchase And Sale | $-712,000 | $-626,000 | $-601,000 | $-692,000 |
| Purchase Of Intangibles | $-712,000 | $-626,000 | $-601,000 | $-692,000 |
| Net PPE Purchase And Sale | $-11,960,000 | $-20,130,000 | $-12,140,000 | $-17,874,000 |
| Purchase Of PPE | $-11,960,000 | $-20,130,000 | $-12,140,000 | $-17,874,000 |
| Change In Working Capital | $6,419,000 | $-1,291,000 | $-21,931,000 | $6,688,000 |
| Change In Other Working Capital | $74,000 | $74,000 | $132,000 | $262,000 |
| Change In Other Current Assets | $2,304,000 | $4,144,000 | $-5,345,000 | $-885,000 |
| Change In Payables And Accrued Expense | $13,430,000 | $3,480,000 | $-4,433,000 | $14,945,000 |
| Change In Accrued Expense | $1,754,000 | $-1,840,000 | $-482,000 | $-732,000 |
| Change In Payable | $11,676,000 | $5,320,000 | $-3,951,000 | $15,677,000 |
| Change In Account Payable | $4,188,000 | $2,375,000 | $1,027,000 | $105,000 |
| Change In Tax Payable | $7,488,000 | $2,945,000 | $-4,978,000 | $15,572,000 |
| Change In Income Tax Payable | $7,488,000 | $2,945,000 | $-4,978,000 | $15,572,000 |
| Change In Inventory | $-8,182,000 | $-5,829,000 | $-5,383,000 | $-2,937,000 |
| Change In Receivables | $-1,207,000 | $-3,160,000 | $-6,902,000 | $-4,697,000 |
| Changes In Account Receivables | $-1,207,000 | $-3,160,000 | $-6,902,000 | $-4,697,000 |
| Other Non Cash Items | $545,000 | $3,883,000 | $696,000 | $1,163,000 |
| Stock Based Compensation | $1,050,000 | $1,020,000 | $6,338,000 | $13,440,000 |
| Unrealized Gain Loss On Investment Securities | $145,000 | $76,000 | $1,082,000 | $1,107,000 |
| Asset Impairment Charge | $-336,000 | $318,000 | $3,752,000 | $1,862,000 |
| Depreciation Amortization Depletion | $10,858,000 | $8,574,000 | $4,714,000 | $2,788,000 |
| Depreciation And Amortization | $10,858,000 | $8,574,000 | $4,714,000 | $2,788,000 |
| Amortization Cash Flow | $2,948,000 | $3,025,000 | $1,282,000 | $690,000 |
| Amortization Of Intangibles | $2,948,000 | $3,025,000 | $1,282,000 | $690,000 |
| Depreciation | $7,910,000 | $5,549,000 | $3,432,000 | $2,098,000 |
| Gain Loss On Investment Securities | $218,000 | - | $-954,000 | $1,183,000 |
| Net Income From Continuing Operations | $-12,127,000 | $-16,007,000 | $13,614,000 | $7,624,000 |
| Change In Other Current Liabilities | - | - | - | $-41,153 |
| Earnings Losses From Equity Investments | - | - | - | $0 |
Fetched: 2026-02-02